News | Hemostasis Management
Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial compression device. The PreludeSync Evo is a sterile, single-use, disposable device used to assist in gaining hemostasis of the arterial percutaneous access site following catheterization procedures.
August 29, 2019
Feature | Peripheral Artery Disease (PAD) | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the safety of paclitaxel-coated devices used to treat peripheral artery disease (PAD) following its review of long-term follow-up clinical data. The agency said five-year results from three randomized trials showed an increased mortality rate in patients treated with these devices compared to those treated with uncoated devices. While these data provide reason for caution, the FDA noted that the devices still provide documented short-term benefits, and healthcare providers should consider all options for their PAD patients.
August 28, 2019
AtriCure Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of additional labeling claims for AtriClip left atrial appendage (LAA) management devices. These include changing the indication from occlusion of the LAA to exclusion, and also adding electrical isolation as a labeling claim.
August 28, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of Warwick focuses on hierarchical template matching (HTM) to diagnose cardiac disease without the use of gadolinium contrast. The technique is explored in an article in the journal Scientific Reports.
August 28, 2019
News | Cath Lab
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy heart muscle tissue.
August 27, 2019
News | EP Lab
Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the treatment of heartbeat abnormalities. The facility, which includes a brand new procedural laboratory, will offer patients a state-of-the-art program delivering cutting-edge electrophysiology procedures, including complex ablations, minimally-invasive pacemaker and defibrillator implantations, and structural interventions. The space also includes a newly renovated reception area and a comfortable, tranquil waiting room for patients’ families and friends.
August 27, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Concept Medical was recently granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for below-the-knee (BTK) use of its MagicTouch drug-coated balloon catheter (DCB) for the treatment of peripheral artery disease (PAD). The company is now in a position to potentially disrupt this market and become a threat to larger manufacturers that have an established presence in the peripheral space, according to data and analytics company GlobalData.
August 27, 2019
Feature | Heart Valve Technology
A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve ...
August 27, 2019
News | Cardiovascular Ultrasound
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-based solutions for ultrasound analysis, to provide its cardiac solutions on Terason's point-of-care ultrasound devices.
August 26, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Population Health
Areas with a higher number of fast food restaurants have more heart attacks, according to research presented at the Cardiac Society of Australia and New Zealand (CSANZ) 2019 annual meeting, Aug. 8-11 in Adelaide, Australia. The study also found that for every additional fast food outlet, there were four additional heart attacks per 100,000 people each year.
August 26, 2019
Patients with peripheral artery disease (PAD) were significantly less likely to face amputation after surgical intervention if they were on statin medications, according to a newly released report in the Journal for Vascular Surgery.1 Those patients also had fewer deaths over the 88-month review period.
August 23, 2019
Technology | Catheters
August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...
August 23, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Podcast | Structural Heart
John Carroll, M.D., FACC, FSCAI, director of interventional cardiology at the Cardiac and Vascular Center at the ...
August 23, 2019
Videos | Chronic Total Occlusion (CTO)
Interview with Kevin Rogers, M.D., director of vascular medicine at the University of Colorado Hospital. He explains ...
August 23, 2019
News | Stem Cell Therapies
August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion of ...
August 22, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now